Swiss HLG and Nordic PLG Webinar

Seeing Value Where Others Saw Risk and How Strategic Conviction Leads to Competitive Advantage: The acquisition of the Swedish biotechnology company Abliva by Pharming

On the October 21st 2026, from 14:00–16:00 CEST we invite you to go behind the scenes of Pharming's acquisition of Abliva and gain unique insights from the executives who led this transformative transaction.

Hear firsthand from Ellen Wittmack Donnelly and Dr. Alexander Breidenbach: Why Pharming Group pursued the acquisition of Abliva

- The strategic vision behind the deal
- Key negotiation challenges and how they were addressed
- Lessons learned throughout the acquisition process
- How strategic conviction can unlock opportunities and create competitive advantage

This webinar is a unique opportunity for professionals in biotech, pharma, business development, corporate strategy, and M&A to learn directly from the dealmakers themselves.

Date: 21 October 2026
Time: 14:00–16:00 CEST